In a New Zealand study7, VEGFR-1 and VEGFR-2, but not VEGFR-3, correlated with lymph node involvement; while, in a UK study10, VEGFR-3 did not act as an independent prognostic marker for survival in CRC patients. The gene discussed is FLT4; the disease is colorectal carcinoma.